TTK Healthcare reported a 19.6% decline in net profit for the year ended March 31, 2026, to ₹656.8 crore, despite a 7% rise in revenue from operations to ₹8,572.8 crore. The decline was primarily due to exceptional charges amounting to ₹757.87 lakh recognized in the third quarter, resulting from the incremental impact of new Labour Codes. The board recommended a dividend of ₹10 per equity share, subject to shareholder approval at the Annual General Meeting, and approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of five years effective from November 1, 2026.

For the fourth quarter ended March 31, 2026, the company posted a net profit of ₹217.6 crore, a significant increase from ₹161.5 crore in the corresponding period of the previous year. Revenue from operations for the quarter stood at ₹2,179.8 crore, compared to ₹1,903.6 crore in Q4 FY25. The statutory auditors, M/s PKF Sridhar & Santhanam LLP, issued an unmodified opinion on the audited financial results.

Financial Results for FY26

The following table summarizes the audited financial results for the year ended March 31, 2026:

Q4 Performance Snapshot

The following table highlights the key quarterly metrics for the period ended March 31, 2026:

Segment Performance

Revenue growth was driven by the Protective Devices and Foods segments. The Protective Devices segment reported annual revenue of ₹2,165.1 crore, while the Foods segment recorded ₹1,511 crore. The Medical Devices segment contributed ₹1,069.2 crore to the total revenue. However, the Protective Devices segment reported a loss before tax and interest of ₹105.4 crore for the year, compared to a profit of ₹25.3 crore in the previous year.

Board Decisions

The Board of Directors approved the reappointment of Mr. T T Raghunathan (DIN: 00043455) as Executive Chairman (Wholetime Director) for a term of five years from November 1, 2026. The remuneration was fixed based on the recommendations of the Nomination and Remuneration Committee. The board also appointed M/s Geeyes & Co. as the Cost Auditor for FY 2026-27 and fixed their remuneration, subject to ratification by shareholders. The 68th AGM is scheduled for July 24, 2026, via Video Conferencing.

TTK Healthcare paid a penalty of ₹9,93,320 to the Customs Department on June 01, 2026, to resolve a dispute regarding the classification of imported products. The payment was made suo motto by the company to close the matter after the department insisted on a penalty equivalent to 15% of the differential duty paid.

The company had been importing various products under Classification 90191010, covering mechanotherapy appliances, which attracted a basic customs duty of 7.5%. Subsequently, the Customs Department indicated that the classification should be under 90191020 for massage apparatus, which carries a basic customs duty of 10%. Upon receiving this information, the company paid the arrears of the differential duty of 2.5% along with the applicable interest.

The filing clarified that there was no suppression of information, and the issue pertained solely to the change in product classification as indicated by the authorities. Despite the payment of arrears, the Customs Department insisted on the penalty. Consequently, the company decided to pay the amount to settle the matter.

The disclosure was made to the exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The payment was confirmed by Gowry A Jaishankar, DGM – Legal & Company Secretary and Compliance Officer.